Privacy Policy
Signals Blog

Contributors

Categories

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Posts by: Stacey


Right Turn: Stem cells, like children, are a labour of love

Author: Stacey Johnson, 03/17/17

For many Canadians with kids, we’re nearing the end of March Break – a holiday from school for elementary- and secondary school-aged children. Whether you’re travelling or at home this week, you’ve spent lots of quality time with your children and this new video from a group at Cambridge may really resonate with you. According […]

Right Turn: My question to Paul Knoepfler: Do you ever sleep?

Author: Stacey Johnson, 03/10/17

Paul Knoepfler, already well known for his prolific blogging at The Niche and for his role as a stem cell educator and tireless patient advocate – award winning no less – has taken on another project. Ask him a question about stem cells and you may get a live response. On February 26th, Dr. Knoepfler, […]

Right Turn: Raising awareness about spinal cerebrospinal fluid (CSF) leak

Author: Stacey Johnson, 03/03/17

Have you heard of spinal cerebrospinal fluid (CSF) leak? No? That’s why the Spinal Cerebrospinal Fluid (CSF) Leak Foundation, established in June 2014, is holding its first educational campaign (Feb. 27-March 3, 2017) to raise awareness of spinal CSF leak, an underdiagnosed cause of headaches that are easily treated and cured. If you suffer from […]

Right Turn: New stem cell product for ALS seeking approval in Canada

Author: Stacey Johnson, 02/24/17

This week, BrainStorm Cell Therapeutics issued a news release announcing its intent to seek early regulatory approval to distribute its Amyotrophic Lateral Sclerosis (ALS) product to patients in Canada. This news was eagerly received by patient groups in Canada and internationally. ALS, also known as Lou Gehrig’s Disease, is a progressive neuromuscular disease in which […]

Right Turn: Checking in on Research2Reality

Author: Stacey Johnson, 02/17/17

Research2Reality will soon be celebrating its 2nd anniversary. I first wrote about it when it launched and was excited by its mission to highlight the work of scientists across Canada, from a variety of disciplines, and make their research interesting and understandable to a non-expert audience. Through videos and blogs, Research2Reality is “shining a light […]